Skip to Content
Merck
CN
  • [Results of open multicenter study of the safety of doxazosin in combination with indigal in men with stages I-II prostatic adenoma].

[Results of open multicenter study of the safety of doxazosin in combination with indigal in men with stages I-II prostatic adenoma].

Urologiia (Moscow, Russia : 1999) (2013-06-26)
V N Pavlov, B K Komiakov, M É Grigor'ev, A V Sivkov, B I Bliumberg, A A Kazikhinoruv, A A Izmaĭlov, A V Boiarko, R A Abzalilov
PMID23789362
ABSTRACT

The article presents a method of conservative treatment of men with I-II stage prostatic adenoma using a combination of doxazosin and indigal, which has antioxidant, antiproliferative and anti-inflammatory properties, that allowed improving urodynamic parameters and reducing the progression prostate adenoma, minimizing the adverse effects of treatment.

MATERIALS
Product Number
Brand
Product Description
68097
Supelco
(−)-Epicatechin, analytical standard
E4018
Sigma-Aldrich
(−)-Epicatechin, ≥98% (HPLC), from green tea
E1753
Sigma-Aldrich
(−)-Epicatechin, ≥90% (HPLC)
03940590
Epicatechin, primary reference standard
43412
Supelco
(+)-Catechin, analytical standard
93894
Supelco
(−)-Epigallocatechin gallate, analytical standard
D9815
Sigma-Aldrich
Doxazosin mesylate, ≥97% (HPLC), powder
E4143
Sigma-Aldrich
(−)-Epigallocatechin gallate, ≥95%
I7256
Sigma-Aldrich
Indole-3-carbinol
E4268
Sigma-Aldrich
(−)-Epigallocatechin gallate, ≥80% (HPLC), from green tea
03970590
Epigallocatechin gallate, primary reference standard